EBV-specific cytotoxic T lymphocytes protect against human EBV-associated lymphoma in scid mice

被引：22

作者：

Buchsbaum, RJ

Fabry, JA

Lieberman, J

机构：

[1] TUFTS UNIV NEW ENGLAND MED CTR,DEPT MED,DIV HEMATOL ONCOL,BOSTON,MA 02111

[2] HARVARD UNIV,SCH MED,CTR BLOOD RES,BOSTON,MA 02115

来源：

IMMUNOLOGY LETTERS | 1996年 / 52卷 / 2-3期

关键词：

Epstein-Barr virus (EBV); cytotoxic T lymphocyte (CTL); lymphoma; scid mice;

D O I：

10.1016/0165-2478(96)02602-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Scid mice develop human EBV-positive B cell tumors after injection with EBV-transformed human B cells or peripheral blood lymphocytes from EBV-seropositive donors. Injection of cytotoxic T cell (CTL) lines, selectively expanded in vitro to recognize autologous EBV-transformed B cells, protected mice against developing human lymphoproliferative disease. CTL protection required a single dose of polyethylene-glycol-conjugated IL2. Mice were not protected by CTL that did not specifically recognize EBV-transformed B cells or by mitogen-activated lymphocytes.

引用

页码：145 / 152

页数：8

共 50 条

[41] Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes
Pepperl, S
Benninger-Döring, G
Modrow, S
Wolf, H
Jilg, W
JOURNAL OF VIROLOGY, 1998, 72 (11) : 8644 - 8649
[42] USE OF HIGHLY CHARACTERIZED EBV-SPECIFIC T CELLS FOR TREATMENT OF EBV plus LYMPHOMA OUTSIDE OF THE HSCT SETTING
Rouce, R. H.
Shah, N.
Thakkar, A.
Sharma, S.
Reyna, A.
Zhang, H.
Mehta, B.
Lulla, P. D.
Pingali, S.
Lapteva, N.
Gee, A.
Leen, A.
Heslop, H.
Rooney, C.
CYTOTHERAPY, 2017, 19 (05) : S43 - S43
[43] A Comprehensive Analysis of the Cellular and EBV-Specific MicroRNAome in Primary CNS PTLD Identifies Different Patterns Among EBV-Associated Tumors
Fink, S. E. K.
Gandhi, M. K.
Nourse, J. P.
Keane, C.
Jones, K.
Crooks, P.
Joehrens, K.
Korfel, A.
Schmidt, H.
Neumann, S.
Tiede, A.
Jaeger, U.
Duehrsen, U.
Neuhaus, R.
Dreyling, M.
Borchert, K.
Suedhoff, T.
Riess, H.
Anagnostopoulos, I.
Trappe, R. U.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (11) : 2577 - 2587
[44] Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (EBV-CTL) home preferentially to and induce selective regressions of autologous B-cell EBV-induced lymphoproliferations (EBV-LPD) in xenografted C.B-17 SCID/SCID (SCID) mice.
Lacerda, JF
Ladanyi, M
Louie, DC
Jagiello, C
Fernandez, JM
Papadopoulos, E
OReilly, RJ
BLOOD, 1995, 86 (10) : 1836 - 1836
[45] EBV specifiv cytotoxic T-CELLS (CTL) or EBV-PCR or both? A new strategy to prevent EBV-specific PTLD.
Wiesmayr, Silke
Stiller, Barbara
Jungraithmayr, Therese
Larcher, Clara
Maecker, Britta
Klein, Christoph
Margreiter, Raimund
Zimmerhackl, Lothar Bernd
PEDIATRIC TRANSPLANTATION, 2007, 11 : 43 - 43
[46] Administration of TGFβ-Resistant Tumor-Specific Cytotoxic T Lymphocytes (CTL) to Patients with EBV-Associated Hodgkin's Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL)
Bollard, Catherine M.
Dotti, Gianpietro
Gottschalk, Stephen
Mims, Martha
Liu, Hao
Gee, Adrian P.
Brenner, Malcolm K.
Heslop, Helen E.
Rooney, Cliona M.
MOLECULAR THERAPY, 2012, 20 : S22 - S23
[47] DONOR T-CELLS TO TREAT EBV-ASSOCIATED LYMPHOMA - REPLY
PAPADOPOULOS, EB
OREILLY, RJ
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (10): : 680 - 680
[48] A case of chronic EBV-associated NK/T cell lymphoma.
Ayuso, R
Maloney, J
Cunningham-Rundles, C
CLINICAL IMMUNOLOGY, 2005, 116 (03) : 281 - 282
[49] Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma
Sun, Q
Burton, R
Reddy, V
Lucas, KG
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (03) : 799 - 808
[50] EPSTEIN-BARR-VIRUS (EBV) INFECTS T-LYMPHOCYTES IN CHILDHOOD EBV-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
SU, IJ
CHEN, RL
KADIN, ME
LABORATORY INVESTIGATION, 1994, 70 (01) : A122 - A122

← 1 2 3 4 5 →